Kulour Trademark Details

This mark is alive with a status of Notice of Allowance - Issued. The last case file activity for this mark occured 8 years ago on Tuesday, April 5, 2016, according to the United State Patent & Trademark Office

Word Mark	Kulour
Status	Alive 688 — Notice of Allowance - Issued

Current Owner

Eli Lilly and Company of Indianapolis, IN

View all trademarks for Eli Lilly and Company

Other Trademarks for Eli Lilly and Company

Serial Number	86782496
Status Date	Tuesday, April 5, 2016
Filing Date	Tuesday, April 5, 2016
Attorney	Bruce W. Longbottom

Correspondent

BRUCE W. LONGBOTTOM
ELI LILLY AND COMPANY
LILLY CORPORATE CENTER
INDIANAPOLIS, IN 46285

Case File Statements

Goods & Services	Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, Parkinson's disease, psychiatric disorders, sleep disorders, urological disorders; antidepressants; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, Parkinson's disease, psychiatric disorders, sleep disorders, urological disorders; antidepressants; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases

Classifications

International Class Codes	005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes	006, 018, 044, 046, 051, 052
Status	6 — Active
Status Date	Wednesday, October 14, 2015
Primary Code	005

Trademark Timeline

Oct 08 2015

Trademark application filed with USPTO
Oct 12 2015

New Application Entered In Tram
Oct 14 2015

New Application Office Supplied Data Entered In Tram
Dec 28 2015

Assigned To Examiner
Jan 04 2016

Approved For Pub - Principal Register
Jan 20 2016

Notification of Notice of Publication E-Mailed
Feb 09 2016

Official Gazette Publication Confirmation E-Mailed
Feb 09 2016

Published For Opposition
Apr 05 2016

Noa E-Mailed - Sou Required From Applicant
Sep 23 2016

Teas Extension Received